Treatment Resistant OCD: - It’s Neurobiology And Treatment Options

Obsessive-compulsive disorder (OCD) is a psychiatric condition with an estimated lifetime prevalence of between 1 and 2%. OCD is considered the fourth most common mental disorder in developed countries, and according to the World Health Organization (WHO), represents the 10th leading cause of disabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Pallabi, Sethi, Rati Ranjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Symposium
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129649/
http://dx.doi.org/10.4103/0019-5545.341857
_version_ 1784712807221035008
author Sahu, Pallabi
Sethi, Rati Ranjan
author_facet Sahu, Pallabi
Sethi, Rati Ranjan
author_sort Sahu, Pallabi
collection PubMed
description Obsessive-compulsive disorder (OCD) is a psychiatric condition with an estimated lifetime prevalence of between 1 and 2%. OCD is considered the fourth most common mental disorder in developed countries, and according to the World Health Organization (WHO), represents the 10th leading cause of disability. Even when optimal treatment is provided, 10% of patients remain severely affected chronically. Through this symposium we want to highlight the neurobiology of treatment resistant OCD and the recent advances in treatment of the same.
format Online
Article
Text
id pubmed-9129649
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91296492022-05-25 Treatment Resistant OCD: - It’s Neurobiology And Treatment Options Sahu, Pallabi Sethi, Rati Ranjan Indian J Psychiatry Symposium Obsessive-compulsive disorder (OCD) is a psychiatric condition with an estimated lifetime prevalence of between 1 and 2%. OCD is considered the fourth most common mental disorder in developed countries, and according to the World Health Organization (WHO), represents the 10th leading cause of disability. Even when optimal treatment is provided, 10% of patients remain severely affected chronically. Through this symposium we want to highlight the neurobiology of treatment resistant OCD and the recent advances in treatment of the same. Wolters Kluwer - Medknow 2022-03 2022-03-24 /pmc/articles/PMC9129649/ http://dx.doi.org/10.4103/0019-5545.341857 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Symposium
Sahu, Pallabi
Sethi, Rati Ranjan
Treatment Resistant OCD: - It’s Neurobiology And Treatment Options
title Treatment Resistant OCD: - It’s Neurobiology And Treatment Options
title_full Treatment Resistant OCD: - It’s Neurobiology And Treatment Options
title_fullStr Treatment Resistant OCD: - It’s Neurobiology And Treatment Options
title_full_unstemmed Treatment Resistant OCD: - It’s Neurobiology And Treatment Options
title_short Treatment Resistant OCD: - It’s Neurobiology And Treatment Options
title_sort treatment resistant ocd: - it’s neurobiology and treatment options
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129649/
http://dx.doi.org/10.4103/0019-5545.341857
work_keys_str_mv AT sahupallabi treatmentresistantocditsneurobiologyandtreatmentoptions
AT sethiratiranjan treatmentresistantocditsneurobiologyandtreatmentoptions

Ejemplares similares